Literature DB >> 18272688

Axonal transport rates in vivo are unaffected by tau deletion or overexpression in mice.

Aidong Yuan1, Asok Kumar, Corrinne Peterhoff, Karen Duff, Ralph A Nixon.   

Abstract

Elevated tau expression has been proposed as a possible basis for impaired axonal transport in Alzheimer's disease. To address this hypothesis, we analyzed the movement of pulse radiolabeled proteins in vivo along retinal ganglion cell (RGC) axons of mice that lack tau or overexpress human tau isoforms. Here, we show that the global axonal transport rates of slow and fast transport cargoes in axons are not significantly impaired when tau expression is eliminated or increased. In addition, markers of slow transport (neurofilament light subunit) and fast transport (snap25) do not accumulate in retinas and are distributed normally along optic axons in mice that lack or overexpress tau. Finally, ultrastructural analyses revealed no abnormal accumulations of vesicular organelles or neurofilaments in RGC perikarya or axons in mice overexpressing or lacking tau. These results suggest that tau is not essential for axonal transport and that transport rates in vivo are not significantly affected by substantial fluctuations in tau expression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18272688      PMCID: PMC2814454          DOI: 10.1523/JNEUROSCI.5242-07.2008

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  21 in total

1.  Neurotrophins are required for nerve growth during development.

Authors:  K L Tucker; M Meyer; Y A Barde
Journal:  Nat Neurosci       Date:  2001-01       Impact factor: 24.884

2.  Loss of brain tau defines novel sporadic and familial tauopathies with frontotemporal dementia.

Authors:  V Zhukareva; V Vogelsberg-Ragaglia; V M Van Deerlin; J Bruce; T Shuck; M Grossman; C M Clark; S E Arnold; E Masliah; D Galasko; J Q Trojanowski; V M Lee
Journal:  Ann Neurol       Date:  2001-02       Impact factor: 10.422

3.  Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform.

Authors:  T Ishihara; M Hong; B Zhang; Y Nakagawa; M K Lee; J Q Trojanowski; V M Lee
Journal:  Neuron       Date:  1999-11       Impact factor: 17.173

4.  Developmentally regulated expression of specific tau sequences.

Authors:  K S Kosik; L D Orecchio; S Bakalis; R L Neve
Journal:  Neuron       Date:  1989-04       Impact factor: 17.173

5.  Brain levels of microtubule-associated protein tau are elevated in Alzheimer's disease: a radioimmuno-slot-blot assay for nanograms of the protein.

Authors:  S Khatoon; I Grundke-Iqbal; K Iqbal
Journal:  J Neurochem       Date:  1992-08       Impact factor: 5.372

6.  Gem GTPase and tau: morphological changes induced by gem GTPase in cho cells are antagonized by tau.

Authors:  Fumitaka Oyama; Svetlana Kotliarova; Akihiro Harada; Mamoru Ito; Haruko Miyazaki; Yoshito Ueyama; Nobutaka Hirokawa; Nobuyuki Nukina; Yasuo Ihara
Journal:  J Biol Chem       Date:  2004-04-15       Impact factor: 5.157

7.  Neurofilament transport in vivo minimally requires hetero-oligomer formation.

Authors:  Aidong Yuan; Mala V Rao; Asok Kumar; Jean-Pierre Julien; Ralph A Nixon
Journal:  J Neurosci       Date:  2003-10-15       Impact factor: 6.167

8.  Immunochemical and biochemical characterization of tau proteins in normal and Alzheimer's disease brains with Alz 50 and Tau-1.

Authors:  H Ksiezak-Reding; L I Binder; S H Yen
Journal:  J Biol Chem       Date:  1988-06-15       Impact factor: 5.157

9.  The slow axonal transport of the microtubule-associated protein tau and the transport rates of different isoforms and mutants in cultured neurons.

Authors:  Michelle A Utton; James Connell; Ayodeji A Asuni; Marjon van Slegtenhorst; Michael Hutton; Rohan de Silva; Andrew J Lees; Chris C J Miller; Brian H Anderton
Journal:  J Neurosci       Date:  2002-08-01       Impact factor: 6.167

10.  Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress.

Authors:  K Stamer; R Vogel; E Thies; E Mandelkow; E-M Mandelkow
Journal:  J Cell Biol       Date:  2002-03-18       Impact factor: 10.539

View more
  81 in total

1.  Pre-synaptic C-terminal truncated tau is released from cortical synapses in Alzheimer's disease.

Authors:  Sophie Sokolow; Kristen M Henkins; Tina Bilousova; Bianca Gonzalez; Harry V Vinters; Carol A Miller; Lindsey Cornwell; Wayne W Poon; Karen H Gylys
Journal:  J Neurochem       Date:  2015-01-13       Impact factor: 5.372

2.  Microarray analysis of CA1 pyramidal neurons in a mouse model of tauopathy reveals progressive synaptic dysfunction.

Authors:  Melissa J Alldred; Karen E Duff; Stephen D Ginsberg
Journal:  Neurobiol Dis       Date:  2011-11-07       Impact factor: 5.996

Review 3.  Axonal degeneration in Alzheimer's disease: when signaling abnormalities meet the axonal transport system.

Authors:  Nicholas M Kanaan; Gustavo F Pigino; Scott T Brady; Orly Lazarov; Lester I Binder; Gerardo A Morfini
Journal:  Exp Neurol       Date:  2012-06-19       Impact factor: 5.330

Review 4.  Microtubule-Tau Interaction as a Therapeutic Target for Alzheimer's Disease.

Authors:  Yanina Ivashko Pachima; Liu-yao Zhou; Peng Lei; Illana Gozes
Journal:  J Mol Neurosci       Date:  2016-02       Impact factor: 3.444

5.  Loss of the m-AAA protease subunit AFG₃L₂ causes mitochondrial transport defects and tau hyperphosphorylation.

Authors:  Arun Kumar Kondadi; Shuaiyu Wang; Sara Montagner; Nikolay Kladt; Anne Korwitz; Paola Martinelli; David Herholz; Michael J Baker; Astrid C Schauss; Thomas Langer; Elena I Rugarli
Journal:  EMBO J       Date:  2014-03-28       Impact factor: 11.598

6.  Amyloid-β/Fyn-induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer's disease.

Authors:  Erik D Roberson; Brian Halabisky; Jong W Yoo; Jinghua Yao; Jeannie Chin; Fengrong Yan; Tiffany Wu; Patricia Hamto; Nino Devidze; Gui-Qiu Yu; Jorge J Palop; Jeffrey L Noebels; Lennart Mucke
Journal:  J Neurosci       Date:  2011-01-12       Impact factor: 6.167

Review 7.  Hyperphosphorylation of microtubule-associated protein tau: a promising therapeutic target for Alzheimer disease.

Authors:  C-X Gong; K Iqbal
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

8.  Tau and Axonal Transport Misregulation in Tauopathies.

Authors:  Benjamin Combs; Rebecca L Mueller; Gerardo Morfini; Scott T Brady; Nicholas M Kanaan
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

9.  Soluble Conformers of Aβ and Tau Alter Selective Proteins Governing Axonal Transport.

Authors:  Mathew A Sherman; Michael LaCroix; Fatou Amar; Megan E Larson; Colleen Forster; Adriano Aguzzi; David A Bennett; Martin Ramsden; Sylvain E Lesné
Journal:  J Neurosci       Date:  2016-09-14       Impact factor: 6.167

10.  Dissociation of tau toxicity and phosphorylation: role of GSK-3beta, MARK and Cdk5 in a Drosophila model.

Authors:  Shreyasi Chatterjee; Tzu-Kang Sang; George M Lawless; George R Jackson
Journal:  Hum Mol Genet       Date:  2008-10-17       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.